Pink Sheet Podcast: US FDA’s Coronavirus-mandated Virtual Advisory Committees, Proventil HFA First Generic, Zofran Liability Suit
Executive Summary
Pink Sheet reporters and editor discuss how the US FDA was pulled into a product liability suit for GSK’s Zofran and the approval of Cipla’s first generic of an albuterol sulfate metered dose inhaler, as well as the agency’s plans for virtual advisory committee meetings.
You may also be interested in...
ANDA Submissions Drop To Start FY2021
First quarter submission volume is the second lowest of the GDUFA era, in part because of BE study problems caused by the pandemic.
Even As Acting US FDA Commissioner, Woodcock Still Holds Multiple Positions
To help with the transition to Biden’s COVID-19 response, Woodcock will retain some therapeutic development duties in the program the Trump administration had called Operation Warp Speed.
Sentinel Could Be Used For Pregnancy Safety Studies Under PDUFA VII
User fee program inflation adjustment also proposed to be changed to account for only PDUFA-related personnel.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: